Myeloid IL-10 receptor signalling as pro-atherogenic factor modulating cholesterol homeostasis

Thromb Haemost 2016; 116(03): 407
DOI: 10.1160/TH16-07-0574

T&H Insights

Schattauer GmbH

Authors

François Mach

¹Division of Cardiology, University of Geneva, Geneva, Switzerland
Karim J. Brandt

¹Division of Cardiology, University of Geneva, Geneva, Switzerland

References
1 Spitz C, Winkels H, Bürger C. et al. Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. Cell Mol Life Sci 2016; 73: 901-922.
2 Li J, McArdle S, Gholami A. et al. CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis. Circ Res 2016; 118: 1540-1552.
3 Strom AC, Cross AJ, Cole JE. et al. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost 2015; 114: 835-847.
4 Halvorsen B, Waehre T, Scholz H. et al. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res 2005; 46: 211-219.
5 Han X, Boisvert WA.. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 2015; 113: 505-512.
6 Stöger JL, Boshuizen MC, Brufau G. et al. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes. Thromb Haemost 2016; 116: 565-577.
7 Allavena P, Piemonti L, Longoni D. et al. IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. Adv Exp Med Biol 1997; 417: 323-327.